Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K253686

True Definition DL

Ge Healthcare Japan Corporation

Authorized purpose: True Definition DL is a deep-learning CT reconstruction function that enhances high-contrast spatial resolution for bone and lung imaging on compatible CT systems.

Modality
CT/CTA
Anatomy
Bone and lungs
Decision
2026-03-23
FDA-cleared K233698

True Enhance DL

GE Healthcare Japan Corporation

Improve contrast of 120 kVp single-energy body CT images by estimating 50 keV GSI-like images as non-quantitative adjunct information for patients of all ages; the original 120 kVp image must remain available for interpretation.

Modality
CT/CTA
Anatomy
Body
Decision
2024-04-11
FDA-cleared K230807

Deep Learning Image Reconstruction

GE Healthcare Japan Corporation

Authorized purpose: Deep Learning Image Reconstruction is a deep-learning reconstruction method that produces cross-sectional images of the head and whole body from X-ray transmission data acquired at different angles and planes, including axial, helical or volumetric, and cardiac acquisitions for all ages. It can be used for head, whole-body, cardiac, and vascular CT applications.

Modality
CT/CTA
Anatomy
Head, whole body, cardiac, and vascular anatomy
Decision
2023-04-20
FDA-cleared K220961

Deep Learning Image Reconstruction

GE Healthcare Japan Corporation

TrueFidelity deep-learning CT reconstruction produces selectable-strength images for supported head, whole-body, cardiac, and vascular applications on the Discovery CT750 HD family.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2022-07-29
FDA-cleared K213938

Revolution Ascend

GE Healthcare Japan Corporation

Authorized purpose: Revolution Ascend produces axial, cine, helical, cardiac, and gated CT images from X-ray transmission data with or without contrast, with post-processing and analysis for head, whole-body, cardiac, and vascular diagnosis, therapy planning, guidance, and monitoring.

Modality
CT/CTA
Anatomy
Head, whole body, cardiac, and vascular anatomy
Decision
2022-02-04
FDA-cleared K212067

Deep Learning Image Reconstruction

GE Healthcare Japan Corporation

TrueFidelity deep-learning CT reconstruction produces selectable-strength images for supported head, whole-body, cardiac, and vascular applications on Revolution Ascend.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2021-09-17
FDA-cleared K203169

Revolution Ascend

GE Healthcare Japan Corporation

Authorized purpose: Revolution Ascend is a diagnostic CT system for acquisition, reconstruction, display, and professional interpretation in the labeled scanner and protocol workflow.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2020-11-20
FDA-cleared K193170

Deep Learning Image Reconstruction

GE Healthcare Japan Corporation

TrueFidelity deep-learning CT reconstruction produces selectable-strength images for supported head, whole-body, cardiac, and vascular applications on Revolution EVO.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2019-12-13